Cargando…

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.

An analysis of prognostic factors has been performed on 260 patients with high and intermediate grade non-Hodgkin's lymphoma (NHL) treated over an 11-year period between 1975 and 1986. The overall 5-year survival rate was 50% with a median follow-up of 72 months. Over 20 clinical, radiological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cowan, R. A., Jones, M., Harris, M., Steward, W. P., Radford, J. A., Wagstaff, J., Deakin, D. P., Crowther, D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247014/ https://www.ncbi.nlm.nih.gov/pubmed/2930692

Ejemplares similares

DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
por: Cowan, R. A., et al.
Publicado: (1989)

Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
por: Dhaliwal, H. S., et al.
Publicado: (1993)

Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
por: Radford, J. A., et al.
Publicado: (1994)

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.
por: Woll, P. J., et al.
Publicado: (1995)

A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
por: Anderson, H., et al.
Publicado: (1984)

Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy.
por: Lee, S. M., et al.
Publicado: (1997)

Involved field radiotherapy or chemotherapy in the management of stage I nodal intermediate grade non-Hodgkin's lymphoma.
por: Jeffery, G. M., et al.
Publicado: (1991)

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas.
por: Bellesi, G., et al.
Publicado: (1989)

PA03.13. Effect of triphaladi rasayana along with yoga therapy on low grade non hodgkins lymphoma and resistant intermediate and high grade non hodgkins lymphoma
por: Soumya, MS Surya, et al.
Publicado: (2013)

A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party.
por: Hayward, R. L., et al.
Publicado: (1991)

Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres.
por: Wagstaff, J., et al.
Publicado: (1988)

Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.
por: Rohatiner, A. Z., et al.
Publicado: (1987)

New approaches to the management of patients with non-Hodgkin's lymphoma of high-grade pathology. First Gordon Hamilton-Fairley memorial lecture.
por: Crowther, D.
Publicado: (1981)

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.
por: Lee, S. M., et al.
Publicado: (1998)

Malignant Lymphomas other than Hodgkins's Disease
por: Crowther, D.
Publicado: (1981)

Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification.
por: Hickish, T. F., et al.
Publicado: (1991)

Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP
por: Messori, A, et al.
Publicado: (2001)

Colchicine ultrasensitivity of peripheral-blood lymphocytes from patients with non-Hodgkin's lymphoma.
por: Scarffe, J. H., et al.
Publicado: (1980)

The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function.
por: Radford, J. A., et al.
Publicado: (1990)

Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes
por: Taylor, G M, et al.
Publicado: (1999)

Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
por: Kesavan, Murali, et al.
Publicado: (2019)

Lymphocyte markers in non-Hodgkin's lymphomas.
por: Payne, S. V., et al.
Publicado: (1977)

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors
por: Cooke, R, et al.
Publicado: (2013)

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage
por: Howell, S J, et al.
Publicado: (2009)

DNA content and prognosis of non-Hodgkin's lymphoma.
por: Morgan, D. R., et al.
Publicado: (1986)

Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?
por: Child, J. A.
Publicado: (1991)

Prognostic Factors in Hodgkin Lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2014)

T‐cell‐derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
por: Bein, Julia, et al.
Publicado: (2022)

Studies of lectin binding to normal and neoplastic lymph nodes. II. Non-Hodgkin's lymphoma.
por: Bramwell, V. H., et al.
Publicado: (1982)

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
por: Johnson, P. W., et al.
Publicado: (1993)

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
por: Blackhall, F H, et al.
Publicado: (2001)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Diagnosis of B-Cell Non-Hodgkin Lymphomas with Small-/Intermediate-Sized Cells in Cytopathology
por: Schwock, Joerg, et al.
Publicado: (2012)

In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma.
por: Shamash, J., et al.
Publicado: (1998)

Hodgkin's Disease
por: Crowther, D.
Publicado: (1981)

Heritability of childhood leukaemia and non-Hodgkin lymphoma
por: Hawkins, M M, et al.
Publicado: (1996)

PCR clonality detection in Hodgkin lymphoma
por: Hebeda, K. M., et al.
Publicado: (2009)

Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
por: Klemi, P. J., et al.
Publicado: (1992)

NonHodgkin's Lymphoma with Peritoneal Localization
por: Curakova, E., et al.
Publicado: (2014)

A case of pericardial schistosomiasis and non-Hodgkin high grade B-cell lymphoma
por: Boyd, Michael J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ooh2ucspbuj9sf7rr57j7titg